Diabetes associated metabolomic perturbations in NOD mice

Metabolomics

Volumn 11, Issue 2, 2015, Pages 425-437

  Grapov, Dmitry ^a   Fahrmann, Johannes ^a   Hwang, Jessica ^b   Poudel, Ananta ^b   Jo, Junghyo ^c,d   Periwal, Vipul ^c   Fiehn, Oliver ^a   Hara, Manami ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d Asia Pacific Center for Theoretical Physics (APCTP)   (South Korea)

Author keywords

Beta cell loss; Metabolomics; Pancreatic beta cells; Type 1 diabetes

Indexed keywords

1,5 ANHYDROSORBITOL; 2 HYDROXYVALERIC ACID; 3 HYDROXYBUTYRIC ACID; 3,6 ANHYDROGALACTOSE; ALLANTOIN; ARACHIDONIC ACID; BETA ALANINE; CELLOBIOTOL; CREATININE; CYSTEINE; GLUCONIC ACID; HISTIDINE; ISOLEUCINE; KETONE BODY; LYSINE; MALTOSE; METHYLHEXADECANOIC ACID; NITRIC OXIDE; ORNITHINE; PANTOTHENIC ACID; PEPTIDES AND PROTEINS; RIBITOL; SACCHARIC ACID; THREONIC ACID; UNCLASSIFIED DRUG; VALINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; BLOOD VESSEL; CONTROLLED STUDY; DISEASE COURSE; ENDOPLASMIC RETICULUM STRESS; FEMALE; GAS CHROMATOGRAPHY; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTIC INFILTRATION; MALE; METABOLITE; METABOLOMICS; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; TIME OF FLIGHT MASS SPECTROMETRY; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84930861884     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-014-0706-2     Document Type: Article

References (61)

1. Adeva, M. M., Calvino, J., Souto, G., & Donapetry, C. (2012). Insulin resistance and the metabolism of branched-chain amino acids in humans. Amino Acids,43, 171–181.
2. Akirav, E., Kushner, J. A., & Herold, K. C. (2008). Beta-cell mass and type 1 diabetes: Going, going, gone? Diabetes,57, 2883–2888.
3. Bankar, S. B., Bule, M. V., Singhal, R. S., & Ananthanarayan, L. (2009). Glucose oxidase: An overview. Biotechnology Advances,27, 489–501.
4. Barupal, D. K., Haldiya, P. K., Wohlgemuth, G., Kind, T., Kothari, S. L., Pinkerton, K. E., et al. (2012). MetaMapp: Mapping and visualizing metabolomic data by integrating information from biochemical pathways and chemical and mass spectral similarity. BMC Bioinformatics,13, 99.
5. Benjamini, Y., & Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B-Methodological,57, 289–300.
6. Bolton, E. E., Chen, J., Kim, S., Han, L., He, S., Shi, W., et al. (2011). PubChem3D: A new resource for scientists. Journal of Cheminformatics,3, 32.
7. Castelo, R., & Roverato, A. (2009). Reverse engineering molecular regulatory networks from microarray data with qp-graphs. Journal of Computational Biology,16, 213–227.
8. Chen, M., Yang, Z. D., Smith, K. M., Carter, J. D., & Nadler, J. L. (2005). Activation of 12-lipoxygenase in proinflammatory cytokine-mediated beta cell toxicity. Diabetologia,48, 486–495.
9. Davidson, M. B., & Schriger, D. L. (2010). Effect of age and race/ethnicity on HbA1c levels in people without known diabetes mellitus: implications for the diagnosis of diabetes. Diabetes Research and Clinical Practice,87, 415–421.
10. Dutta, T., Chai, H. S., Ward, L. E., Ghosh, A., Persson, X. M., Ford, G. C., et al. (2012). Concordance of changes in metabolic pathways based on plasma metabolomics and skeletal muscle transcriptomics in type 1 diabetes. Diabetes,61, 1004–1016.
11. Fiehn, O., Wohlgemuth, G., & Scholz, M. (2005). Setup and annotation of metabolomic experiments by integrating biological and mass spectrometric metadata. In B. Ludäscher & L. Raschid (Eds.), Lecture Notes in Computer Science (Vol. 3615, pp. 224–239)., Data integration in the life sciences Berlin Heidelberg: Springer.
12. Fiehn, O., Wohlgemuth, G., Scholz, M., Kind, T., Lee do, Y., Lu, Y., et al. (2008). Quality control for plant metabolomics: Reporting MSI-compliant studies. Plant Journal,53, 691–704.
13. Gianani, R., Campbell-Thompson, M., Sarkar, S. A., Wasserfall, C., Pugliese, A., Solis, J. M., et al. (2010). Dimorphic histopathology of long-standing childhood-onset diabetes. Diabetologia,53, 690–698.
14. Grapov, D., Adams, S. H., Pedersen, T. L., Garvey, W. T., & Newman, J. W. (2012). Type 2 diabetes associated changes in the plasma non-esterified fatty acids, oxylipins and endocannabinoids. PLoS One,7, e48852.
15. Heitmeier, M. R., Kelly, C. B., Ensor, N. J., Gibson, K. A., Mullis, K. G., Corbett, J. A., et al. (2004). Role of cyclooxygenase-2 in cytokine-induced beta-cell dysfunction and damage by isolated rat and human islets. Journal of Biological Chemistry,279, 53145–53151.
16. Holohan, C., Szegezdi, E., Ritter, T., O’Brien, T., & Samali, A. (2008). Cytokine-induced beta-cell apoptosis is NO-dependent, mitochondria-mediated and inhibited by BCL-XL. Journal of Cellular and Molecular Medicine,12, 591–606.
17. Jo, J., Kilimnik, G., Kim, A., Guo, C., Periwal, V., & Hara, M. (2011). Formation of pancreatic islets involves coordinated expansion of small islets and fission of large interconnected islet-like structures. Biophysical Journal,101, 565–574.
18. Juraschek, S. P., Steffes, M. W., Miller, E. R, 3rd, & Selvin, E. (2012). Alternative markers of hyperglycemia and risk of diabetes. Diabetes Care,35, 2265–2270.
19. Kacheva, S., Lenzen, S., & Gurgul-Convey, E. (2011). Differential effects of proinflammatory cytokines on cell death and ER stress in insulin-secreting INS1E cells and the involvement of nitric oxide. Cytokine,55, 195–201.
20. Kalogeropoulou, D., LaFave, L., Schweim, K., Gannon, M. C., & Nuttall, F. Q. (2009). Lysine ingestion markedly attenuates the glucose response to ingested glucose without a change in insulin response. American Journal of Clinical Nutrition,90, 314–320.
21. Kanehisa, M., Goto, S., Sato, Y., Furumichi, M., & Tanabe, M. (2012). KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Research,40(Database issue), D109–D114.
22. Kawasaki, H., Hori, T., Nakajima, M., & Takeshita, K. (1988). Plasma levels of pipecolic acid in patients with chronic liver disease. Hepatology,8, 286–289.
23. Kilimnik, G., Jo, J., Periwal, V., Zielinski, M. C., & Hara, M. (2012). Quantification of islet size and architecture. Islets,4, 167–172.
24. Kilimnik, G., Kim, A., Jo, J., Miller, K., & Hara, M. (2009). Quantification of pancreatic islet distribution in situ in mice. American Journal of Physiology - Endocrinology and Metabolism,297, E1331–E1338.
25. Kim, A., Miller, K., Jo, J., Kilimnik, G., Wojcik, P., & Hara, M. (2009). Islet architecture: A comparative study. Islets,1, 129–136.
26. Kolb, H., & Kolb-Bachofen, V. (1992). Type 1 (insulin-dependent) diabetes mellitus and nitric oxide. Diabetologia,35, 796–797.
27. Lanza, I. R., Zhang, S., Ward, L. E., Karakelides, H., Raftery, D., & Nair, K. S. (2010). Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes. PLoS One,5, e10538.
28. Lebastchi, J., & Herold, K. C. (2012). Immunologic and metabolic biomarkers of beta-cell destruction in the diagnosis of type 1 diabetes. Cold Spring Harbor Perspectives in Medicine,2, a007708.
29. Liu, Z., Jeppesen, P. B., Gregersen, S., Chen, X., & Hermansen, K. (2008). Dose- and glucose-dependent effects of amino acids on insulin secretion from isolated mouse islets and clonal INS-1E beta-cells. Review of Diabetic Studies,5, 232–244.
30. Lu, J., Zhou, J., Bao, Y., Chen, T., Zhang, Y., Zhao, A., et al. (2012). Serum metabolic signatures of fulminant type 1 diabetes. Journal of Proteome Research,11, 4705–4711.
31. Madsen, R., Banday, V. S., Moritz, T., Trygg, J., & Lejon, K. (2012). Altered metabolic signature in pre-diabetic NOD mice. PLoS One,7, e35445.
32. Maritim, A. C., Sanders, R. A., & Watkins, J. B, 3rd. (2003). Diabetes, oxidative stress, and antioxidants: A review. Journal of Biochemical and Molecular Toxicology,17, 24–38.
33. McKillop, A. M., & Flatt, P. R. (2011). Emerging applications of metabolomic and genomic profiling in diabetic clinical medicine. Diabetes Care,34, 2624–2630.
34. Meier, J. J., Bhushan, A., Butler, A. E., Rizza, R. A., & Butler, P. C. (2005). Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: Indirect evidence for islet regeneration? Diabetologia,48, 2221–2228.
35. Miller, K., Kim, A., Kilimnik, G., Jo, J., Moka, U., Periwal, V., et al. (2009). Islet formation during the neonatal development in mice. PLoS One,4, e7739.
36. Mori, M. (2007). Regulation of nitric oxide synthesis and apoptosis by arginase and arginine recycling. Journal of Nutrition,137, 1616S–1620S.
37. Nakagawa, Y., & Ishii, E. (1996). Changes in arachidonic acid metabolism and the aggregation of polymorphonuclear leukocytes in rats with streptozotocin-induced diabetes. Biochimica et Biophysica Acta,1315, 145–151.
38. Newgard, C. B. (2012). Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metabolism,15, 606–614.
39. Nokoff, N., & Rewers, M. (2013). Pathogenesis of type 1 diabetes: Lessons from natural history studies of high-risk individuals. Annals of the New York Academy of Sciences,1281, 1–15.
40. Oresic, M., Seppanen-Laakso, T., Sun, D., Tang, J., Therman, S., Viehman, R., et al. (2012). Phospholipids and insulin resistance in psychosis: A lipidomics study of twin pairs discordant for schizophrenia. Genome Medicine,4, 1.
41. Oresic, M., Simell, S., Sysi-Aho, M., Nanto-Salonen, K., Seppanen-Laakso, T., Parikka, V., et al. (2008). Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. Journal of Experimental Medicine,205, 2975–2984.
42. Oyadomari, S., Takeda, K., Takiguchi, M., Gotoh, T., Matsumoto, M., Wada, I., et al. (2001). Nitric oxide-induced apoptosis in pancreatic beta cells is mediated by the endoplasmic reticulum stress pathway. Proceedings of the National Academy of Sciences USA,98, 10845–10850.
43. Palermo, G., Piraino, P., & Zucht, H. D. (2009). Performance of PLS regression coefficients in selecting variables for each response of a multivariate PLS for omics-type data. Advances and Applications in Bioinformatics and Chemistry,2, 57–70.
44. Parazzoli, S., Harmon, J. S., Vallerie, S. N., Zhang, T., Zhou, H., & Robertson, R. P. (2012). Cyclooxygenase-2, not microsomal prostaglandin E synthase-1, is the mechanism for interleukin-1beta-induced prostaglandin E2 production and inhibition of insulin secretion in pancreatic islets. Journal of Biological Chemistry,287, 32246–32253.
45. Pflueger, M., Seppanen-Laakso, T., Suortti, T., Hyotylainen, T., Achenbach, P., Bonifacio, E., et al. (2011). Age- and islet autoimmunity-associated differences in amino acid and lipid metabolites in children at risk for type 1 diabetes. Diabetes,60, 2740–2747.
46. R Development Core Team. R: A language and environment for statistical computing. (2011). R Foundation for Statistical Computing, ISBN 3-900051-900007-900050.
47. Robinson, T. W., & Freedman, B. I. (2013). Assessing glycemic control in diabetic patients with severe nephropathy. Journal of Renal Nutrition,23, 199–202.
48. 2-induced pancreatic beta cell death. Apoptosis,15, 1165–1176.
49. Scholz, M., & Fiehn, O. (2007). SetupX: A public study design database for metabolomic projects. Pacific Symposium on Biocomputing,12, 169–180.
50. Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., et al. (2003). Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Research,13, 2498–2504.
51. Smith, T. N., Hash, K., Davey, C. L., Mills, H., Williams, H., & Kiely, D. E. (2012). Modifications in the nitric acid oxidation of d-glucose. Carbohydrate Research,350, 6–13.
52. Southern, C., Schulster, D., & Green, I. C. (1990). Inhibition of insulin secretion by interleukin-1 beta and tumour necrosis factor-alpha via an l-arginine-dependent nitric oxide generating mechanism. FEBS Letters,276, 42–44.
53. Standards of medical care in diabetes 2013. (2013). Diabetes Care,36, S11.
54. Stojanovic, V., & Ihle, S. (2011). Role of beta-hydroxybutyric acid in diabetic ketoacidosis: A review. Canadian Veterinary Journal,52, 426–430.
55. Strimmer, K. (2008). fdrtool: A versatile R package for estimating local and tail area-based false discovery rates. Bioinformatics,24, 1461–1462.
56. Svensson, O., Kourti, T., & MacGregor, J. F. (2002). An investigation of orthogonal signal correction algorithms and their characteristics. Journal of Chemometrics,16, 176–188.
57. Sysi-Aho, M., Ermolov, A., Gopalacharyulu, P. V., Tripathi, A., Seppanen-Laakso, T., Maukonen, J., et al. (2011). Metabolic regulation in progression to autoimmune diabetes. PLoS Computational Biology,7, e1002257.
58. Tran, P. O., Gleason, C. E., & Robertson, R. P. (2002). Inhibition of interleukin-1beta-induced COX-2 and EP3 gene expression by sodium salicylate enhances pancreatic islet beta-cell function. Diabetes,51, 1772–1778.
59. Wang, T. J., Larson, M. G., Vasan, R. S., Cheng, S., Rhee, E. P., McCabe, E., et al. (2011). Metabolite profiles and the risk of developing diabetes. Nature Medicine,17, 448–453.
60. Wiklund, S., Johansson, E., Sjostrom, L., Mellerowicz, E. J., Edlund, U., Shockcor, J. P., et al. (2008). Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Analytical Chemistry,80, 115–122.
61. Ziemer, D. C., Kolm, P., Weintraub, W. S., Vaccarino, V., Rhee, M. K., Twombly, J. G., et al. (2010). Glucose-independent, black-white differences in hemoglobin A1c levels: A cross-sectional analysis of 2 studies. Annals of Internal Medicine,152, 770–777.